FY2020 · ended Dec 31, 2020 · Revenue $1.07B, +0.0% YoY · Filed Mar 15, 2022
Bone Biologics Corporation (BBLG) files with the SEC under industry code 3842, Orthopedic, Prosthetic & Surgical Appliances & Supplies.
Revenue (TTM)
$1.07B
Net income (TTM)
$-1.77M
+14.4% vs year-ago TTM
Operating cash flow (TTM)
$-2.57M
+22.8% vs year-ago TTM
Free cash flow
—
EPS
$-2.65
+90.8% vs prior year
Dividend per share
None
Shares outstanding
1.80M
-45.1% vs prior year
Net cash
—
Operating margin
-0.1%
FY 2021
Company profile
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
- Listed as
- BBLG (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Burlington, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1419554
- Former names
- Bone Biologics, Corp. (until Nov 2, 2015); AFH ACQUISITION X, INC. (until Sep 15, 2014)
Other Orthopedic, Prosthetic & Surgical Appliances & Supplies companies
- Intuitive Surgical Inc ISRG
- Edwards Lifesciences Corp EW
- STERIS plc STE
- Zimmer Biomet Holdings, Inc. ZBH
- Smith & Nephew PLC SNN
- Align Technology Inc ALGN
- MSA Safety Inc MSA
- Establishment Labs Holdings Inc. ESTA
All 29 Orthopedic, Prosthetic & Surgical Appliances & Supplies companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Operating income | -$3.2M | -$4.2M | -$9.4M | -$3.7M | -$1.1M |
| Net income | -$3.1M | -$4.1M | -$8.9M | -$1.5M | -$1.6M |
| Diluted EPS | -$2.65 | -$28.96 | -$34.01 | — | — |
| Operating cash flow | -$2.7M | -$4.1M | -$9.6M | -$3.6M | -$1.2M |
| Total assets | $5.8M | $3.9M | $3.7M | $8.5M | $6.7M |
| Total liabilities | $418,587 | $377,712 | $831,402 | $2.5M | $99,909 |
| Stockholders' equity | $5.4M | $3.5M | $2.9M | $5.9M | $6.6M |
| Cash and investments | $5.3M | $3.3M | $3.0M | $7.5M | $6.7M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Oct 26, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Sep 29, 2026 | Sep 28, 2026 |
| 8-K |
Current report
Listing notice
|
Sep 16, 2026 | Sep 10, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 23, 2026 | Jul 23, 2026 |
| 8-K |
Current report
Other events
|
Jul 16, 2026 | Jul 15, 2026 |
All 485 Bone Biologics Corporation SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.